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Summary
The LEM domain (for lamina-associated polypeptide, emerin, MAN1 domain) defines a group of nuclear proteins that bind chromatin
through interaction of the LEM motif with the conserved DNA crosslinking protein, barrier-to-autointegration factor (BAF). Here, we
describe a LEM protein annotated in databases as ‘Ankyrin repeat and LEM domain-containing protein 1’ (Ankle1). We show that
Ankle1 is conserved in metazoans and contains a unique C-terminal GIY-YIG motif that confers endonuclease activity in vitro and in
vivo. In mammals, Ankle1 is predominantly expressed in hematopoietic tissues. Although most characterized LEM proteins are
components of the inner nuclear membrane, ectopic Ankle1 shuttles between cytoplasm and nucleus. Ankle1 enriched in the
nucleoplasm induces DNA cleavage and DNA damage response. This activity requires both the catalytic C-terminal GIY-YIG domain
and the LEM motif, which binds chromatin via BAF. Hence, Ankle1 is an unusual LEM protein with a GIY-YIG-type endonuclease
activity in higher eukaryotes.
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Introduction
Polypeptides containing a LEM (for lamina-associated
polypeptide, emerin, MAN1) domain (Lin et al., 2000) comprise
a protein family with important and essential functions in
nuclear architecture, mitosis, cell signaling and gene expression
(Gruenbaum et al., 2005; Schirmer and Foisner, 2007; Wagner and
Krohne, 2007; Anderson and Hetzer, 2008). The LEM domain is a
structural motif of 45 amino acids that folds as two a-helices
(Laguri et al., 2001) and binds to barrier-to-autointegration factor
(BAF) (Furukawa, 1999; Cai et al., 2001; Shumaker et al., 2001),
an essential DNA crosslinking protein in metazoans (Umland et al.,
2000; Zheng et al., 2000; Margalit et al., 2007).
The LEM protein family in mammals includes the well-
characterized proteins lamina-associated polypeptide 2 (LAP2),
emerin and MAN1 (Schirmer and Foisner, 2007; Wagner and
Krohne, 2007), the MAN1-related protein LEM domain-
containing protein 2 (LEM2) (Brachner et al., 2005; Chen et al.,
2006; Ulbert et al., 2006; Huber et al., 2009) and a partially
characterized testis-specific protein, LEM domain-containing
protein 1 (LEMD1, also known as LEM5) (Lee and Wilson,
2004; Yuki et al., 2004). Two of these proteins (emerin and
LEM2) are conserved in Caenorhabditis elegans (Lee et al.,
2000; Gruenbaum et al., 2002; Liu et al., 2003). Most of the
characterized LEM proteins are transmembrane proteins of the
inner nuclear membrane where they interact with the nuclear
lamina (Schirmer and Foisner, 2007; Wagner and Krohne, 2007).
LEM protein–BAF complexes are involved in post-mitotic
nuclear assembly and in chromatin organization in C. elegans
(Liu et al., 2003; Margalit et al., 2005) and in mammalian cells
(Haraguchi et al., 2001; Dechat et al., 2004; Shimi et al., 2004).
In addition, several LEM domain proteins bind to and regulate
transcription factors and signaling molecules such as b-catenin
(Markiewicz et al., 2006), Smads (Lin et al., 2005; Pan et al.,
2005; Jiang et al., 2008), germ-cell-less (gcl) (Nili et al., 2001;
Holaska et al., 2003) and retinoblastoma protein (Markiewicz
et al., 2002; Dorner et al., 2006). Mutations in genes encoding
emerin, MAN1 and LAP2a have been linked to a number of
human pathologies (Vlcek and Foisner, 2007; Wagner and
Krohne, 2007; Worman and Bonne, 2007; Chi et al., 2009),
reflecting their multiple and diverse functions.
In silico analyses of mammalian genomes have identified
previously unknown genes encoding proteins predicted to be
members of the LEM family, originally termed LEM3 and LEM4
(Lee et al., 2000; Lee and Wilson, 2004) and annotated in
databases as Ankyrin repeat and LEM domain-containing
proteins 1 and 2, respectively. In this study, we report the first
biochemical and cell biological characterization of Ankle1 [also
known as LEM3, Ankyrin repeat domain-containing protein 41
(ANKRD41) and FLJ39369], an evolutionary conserved non-
membrane-bound LEM protein that shuttles between nucleus and
cytoplasm and is predominantly expressed in hematopoietic
tissues and cells.
Intriguingly, the Ankle1 C-terminus contains an enzymatically
active GIY-YIG endonuclease domain, previously described
as the characteristic feature of a subgroup of the homing
endonuclease superfamily. Homing endonucleases are encoded
within ‘selfish’ group I introns or inteins. They catalyze their
lateral transfer and integration into intronless homologous alleles
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in the host genome (Stoddard, 2005; Edgell, 2009; Stoddard,
2011). A large number of these enzymes have been identified in
all three biological kingdoms: archae, bacteria and eukaryotes
(Belfort and Roberts, 1997; Sokolowska et al., 2011). The GIY-
YIG homing endonucleases that have been characterized in detail
include I-TevI in T4 phage (Bell-Pedersen et al., 1991; Van Roey
et al., 2002) and I-SceI in the yeast mitochondrial genome (Perrin
et al., 1993; Moure et al., 2003). The GIY-YIG motif has also
been found in enzymes other than homing endonucleases, such as
UvrC, a protein involved in nucleotide excision repair in bacteria
(Yoakum and Grossman, 1981; Truglio et al., 2005). Only a
few genes in higher eukaryotes are known to encode proteins
that contain a GIY-YIG motif: the recently characterized gene
encoding human endonuclease SLX1, which is involved in
structure-specific DNA repair (Fekairi et al., 2009; Svendsen
et al., 2009), the transpositionally active Penelope-like elements
in Drosophila virilis (Pyatkov et al., 2004; Evgen’ev and
Arkhipova, 2005; Schostak et al., 2008) and the as-yet-
uncharacterized human gene encoding Ankle1 (Dunin-
Horkawicz et al., 2006).
Results
Ankle1 is highly conserved in metazoans
ANKLE1 is also termed ANKRD41, FLJ39369 or LEM3 and was
annotated in databases on the basis of different computational
screens for genes encoding proteins that contain either a
LEM domain, Ankyrin repeats or a GIY-YIG motif (Lee et al.,
2000; Lee and Wilson, 2004; Dunin-Horkawicz et al., 2006).
Assembly and alignment of Ankle1 sequences from numerous
species obtained from the ENSEMBL and NCBI databases
(supplementary material Fig. S1A) revealed a conserved domain
organization of the protein (see Fig. 1): two to four (depending
on the species) N-terminal Ankyrin repeats, a central putative
LEM domain, and a predicted C-terminal GIY-YIG motif
within a highly conserved C-terminal sequence stretch termed
‘PB014249’ in the Pfam database (www.pfam.sanger.ac.uk). This
latter C-terminal domain including the GIY-YIG motif showed
the highest homologies, ranging from ,70% conserved residues
among vertebrates to ,40% conservation between nematodes
and mammals (Fig. 1; supplementary material Fig. S1B). Unlike
the domain architecture, the predicted molecular weights of
Ankle1 vary considerably, ranging from 58 kDa in mouse to
102 kDa in zebrafish (Fig. 1). Human Ankle1 has 615 residues
and a predicted molecular weight of 65 kDa. The variability in
size is particularly evident in the region between the Ankyrin
repeats and the LEM domain, indicating that the distance
between these domains might be less important for its activity.
By contrast, the spacing between the LEM domain and the GIY-
YIG motif was preserved and might thus be crucial for the
function(s) of Ankle1.
Human Ankle1 is expressed in a tissue-restricted manner
We analyzed the expression levels of Ankle1 in human tissues
and cell lines by semiquantitative RT-PCR using primers for the
39 region of Ankle1 cDNA. Analysis of mRNA samples from a
collection of adult human tissues revealed predominant Ankle1
mRNA expression in bone marrow. Expression was also high in
fetal liver, fetal spleen and fetal thymus, the primary organs
of hematopoiesis during intrauterine development (Fig. 2A),
suggesting that Ankle1 might be involved in hematopoiesis-
specific processes. In addition, we observed expression in a panel
of lymphoma- and leukemia-derived tumor cell lines (ARH77,
CCRF, DAUDI, K562, RAJI, RAMOS and REH), whereas
sarcoma- and carcinoma-derived lines (HACAT, HeLa, LSWW,
MCF-7, SW-480, T-98-G and U2OS) expressed low or
undetectable levels of Ankle1 mRNA (Fig. 2A). RT-PCR
analysis of human bone marrow mRNA samples using a further
upstream forward primer (Fig. 2B) identified a minor, slightly
smaller isoform of Ankle1, originating from alternative splicing
within exon 5 (see also Q8NAG6-1 in the Uniprot database).
Interestingly, the splice variant, which we termed Ankle1b,
lacks half (amino acids 375–400) of the putative LEM domain
(Fig. 2B).
Next, we tested Ankle1 protein expression, using rabbit
polyclonal antibodies raised against the N-terminal recombinant
mouse Ankle1 fragment (amino acids 95–260, antiserum number
136). Although the antibodies readily detected ectopically
expressed Ankle1 in western blots of HeLa cell lysates (Fig. 2C)
(human Ankle1–V5, mouse Ankle1–V5) as well as in
immunofluorescence microscopy (see later), endogenous Ankle1
was not detectable in various human or mouse lymphoma cell lines
that contain abundant Ankle1 mRNA levels (Fig. 2C). We
Fig. 1. Ankle1 is a LEM protein conserved among metazoans. Comparison of the predicted domain organization of Ankle1 orthologs from various species
representing major metazoan clades: Homo sapiens and Mus musculus (mammals), Danio rerio (vertebrates), Strongylocentrotus purpuratus (echinodermata),
Drosophila melanogaster (arthropods) and Caenorhabditis elegans (nematodes). Ankyrin repeats are shown as green boxes, the LEM motif as red boxes and the
C-terminal PB014249 sequence as violet boxes. The predicted GIY-YIG motif is marked as a black-hatched box. Number of amino acids (aa) of full-length
proteins, database accession numbers and the sequence homologies of various domains to human Ankle1 are shown on the right.
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obtained similar results with antibodies raised against a highly
conserved peptide within the C-terminal region (amino acids 388–
402) of mouse Ankle1 (data not shown). Thus, the antisera clearly
detected ectopic Ankle1 protein in mammalian cells in both
the unfolded and native state (western blotting and
immunofluorescence microscopy, respectively), but we could not
detect endogenous Ankle1. Therefore, we assumed that
endogenous Ankle1 protein levels are strictly controlled and
expressed at levels below the detection limit of our assays.
Ankle1 binds to BAF
A characteristic feature of LEM proteins is their interaction with
BAF via the LEM motif. In order to test whether Ankle1 also
binds BAF, we performed in vitro pull-down assays using
recombinant 66histidine-tagged BAF (BAF–His). Bacterial
lysates containing BAF–His were mixed with Escherichia
coli cell lysates expressing recombinant full-length Ankle1, an
Ankle1 fragment (Ankle1DCT) lacking the C-terminus including
the predicted LEM domain and, as a positive control, the N-
terminal part of the LEM protein emerin (EmerinDTM), which
was shown to bind BAF (Lee et al., 2001). BAF–His was
precipitated using magnetic Ni particles and the supernatant and
pellet fractions were analyzed by western blotting. BAF–
His efficiently co-precipitated full-length Ankle1 and emerin,
whereas Ankle1DCT remained in the unbound fraction (Fig. 3A),
indicating that the C-terminal half of Ankle1 binds BAF.
To test whether the LEM domain mediates Ankle1–BAF
interaction, we performed pull-down assays with bacterially
expressed full length 66His-V5-tagged Ankle1 (Ankle1–His-
V5) and the corresponding Ankle1 splice variant lacking a part of
its LEM domain (Ankle1b–His-V5). Precipitation of Ankle1–
His-V5 with Ni beads brought down a significant fraction of
Fig. 2. Ankle1 is predominantly
expressed in human hematopoietic
tissues and cell lines. (A) Representative
agarose gels showing semiquantitative
RT-PCR products amplified from human
tissue and cell line samples. Actin and
GAPDH were used as controls for equal
loading. (B) Resolution of human Ankle1
PCR products from human bone marrow
on polyacrylamide gels revealed a low-
abundance smaller Ankle1 isoform
(Ankle1b). Position of PCR primers are
indicated (primer 1 was used for Ankle1
splice variant identification; primer 2 for
expression analyses). The identity of the
isoform was verified by sequencing.
(C) Representative western blot detecting
Ankle1 protein in total lysates of HeLa
cells expressing ectopic human or mouse
Ankle1–V5. Tubulin was probed as a
loading control.
Fig. 3. Co-precipitates of BAF and Ankle1 in vitro.
(A) BAF-66His was mixed with E.coli lysates containing
recombinant Ankle1, Ankle1DCT or an N-terminal emerin
fragment EmerinDTM and precipitated using Ni beads.
BAF-bound proteins were detected by western blotting
using antiserum ‘136’ (Ankle1), India His-Probe (BAF)
and monoclonal antibody MANEM5 to emerin. Molecular
masses are indicated in kiloDaltons. Ankle1 constructs
used in the assays are shown at the bottom; for key see
Fig. 1. (B) Recombinant 66His-V5-tagged Ankle1,
Ankle1b or LAP2a were incubated with bacterial lysates
containing untagged human BAF. His-tagged prey proteins
were precipitated using Ni beads and bound BAF was
detected by western blotting using antibodies to the V5 tag
and BAF. Note that BAF forms various homomeric
complexes even under denaturating conditions (arrows
indicating monomeric, dimeric and oligomeric states). S,
supernatant fraction (10% of input); P, precipitated fraction
(50% of precipitated proteins).
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recombinant, untagged BAF from bacterial cell lysates (Fig. 3B).
Predominantly dimeric BAF was detected in the Ankle1 pellet
fraction, whereas monomeric and oligomeric BAF mainly
remained in the supernatant fraction. Similar results were
obtained in the positive control using the LEM protein LAP2a,
which efficiently pelleted BAF dimers. By contrast, Ankle1b–
His-V5, lacking a functional LEM domain, precipitated only
trace amounts of BAF, and very little dimeric BAF was detected
in the supernatant and pellet fractions. Overall, these findings
show that Ankle1 interacts directly with BAF via its LEM
domain, and indicate that binding of BAF to the LEM domain
may favor BAF dimerization.
Ankle1 shuttles between cytoplasm and nucleus
Because antisera failed to detect endogenous Ankle1 protein
(Fig. 2C), we expressed GFP-tagged human Ankle1 in a
lymphoma and a carcinoma-derived cell line, expressing or
lacking endogenous Ankle1 mRNA, respectively (Fig. 1A). In
both lymphoma-derived RAMOS cells and HeLa cells we
observed predominant cytoplasmic localization of GFP–Ankle1
by fluorescence microscopy (Fig. 4A). Identical results were
obtained using a C-terminal GFP tag (data not shown) or a small
tag such as V5 (Fig. 4B). Because in silico analyses of the
Ankle1 primary sequence predicted potential nuclear export and
nuclear localization signals (NES and NLS, Fig. 4A, scheme), we
hypothesized that Ankle1 shuttles between the nucleus and
cytoplasm. To test this hypothesis, we blocked Crm-dependent
nuclear export using the drug Leptomycin B (Kudo et al., 1998).
After 1 hour of Leptomycin B treatment, most of the tagged
Ankle1 was accumulated in the nucleus in both HeLa and
RAMOS cells (Fig. 4). Thus, Ankle1 is actively transported in
and out of the nucleus and shows a predominant cytoplasmic
localization at steady state.
Ankle1 has nuclease activity that elicits DNA damage
signaling in the nucleus
Given that Ankle1 contains a putative GIY-YIG-type
endonuclease domain, we performed a series of in vitro and in
vivo assays to test for endonuclease activity. Recombinant Ankle1
purified from HEK cells cleaved supercoiled plasmid DNA into
relaxed circular (nicked) and linearized DNA molecules (Fig. 5A),
suggesting that Ankle1 possesses in vitro nuclease activity. Several
conserved residues in the GIY-YIG motif (Y453, G488, E551 in
human Ankle1, see supplementary material Fig. S3A) were
previously identified as crucial for the formation of the catalytic
surface of the nuclease (Van Roey et al., 2002; Truglio et al., 2005;
Lagerback and Carlson, 2008). Point mutations of either of these
residues abrogated the in vitro DNA cleavage activity of Ankle1
(Fig. 5A). Thus, we concluded that Ankle1 possesses intrinsic
endonuclease activity mediated by its C-terminal canonical GIY-
YIG motif.
Fig. 4. Human Ankle1 shuttles between nucleus and cytoplasm.
(A) GFP-tagged Ankle1 was expressed in HeLa or RAMOS cells and
imaged by live-cell microscopy (GFP) and differential interference
contrast (DIC) microscopy before (2) and after (+) treatment with
Leptomycin for 1 hour. Nuclear export signals (NES) and nuclear
localization signals (NLS) identified by in silico prediction software are
indicated. (B) HeLa cells were transfected with human Ankle1–V5, and
processed for immunofluorescence microscopy before and after 3 hours
of Leptomycin treatment. Scale bars: 10 mm.
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In order to test whether Ankle1 also cleaves DNA in cells in
vivo, we performed COMET (i.e. single-cell gel electrophoresis)
assays, an established method for detecting genomic DNA
fragmentation in vivo at the single-cell level. Expression of GFP–
Ankle1 in HeLa cells for 24 hours caused little DNA damage,
similar to the negative control cells expressing GFP only
(Fig. 5B). By contrast, treatment of cells with Leptomycin,
causing GFP–Ankle1 accumulation in the nucleus, induced
DNA cleavage to a similar extent as cells treated with the
topoisomerase II inhibitor Etoposide, a drug known to induce
massive DNA double-strand breaks (Sullivan et al., 1986).
Leptomycin treatment of cells expressing GFP or a truncated
Ankle1 lacking the C-terminal GIY-YIG motif did not induce
DNA breaks (Fig. 5B).
In order to find out whether Ankle1-mediated DNA cleavage
activates DNA damage signaling, we analyzed the expression and
localization of components of the DNA damage response
pathway in GFP–Ankle1-expressing cells before and after
Leptomycin treatment. In more than 90% of cells (n.100)
nuclear accumulation of GFP–Ankle1 following Leptomycin
treatment caused relocalization of 53BP1 to intranuclear foci
(Schultz et al., 2000), phosphorylation of Histone 2A.X
(cH2A.X) and activation of the downstream effector kinase
Chk2 (pChk2) (Fig. 6A), which was similar to the results in
Etoposide-treated cells (Fig. 6B). Identical results were obtained
in cells expressing Ankle1–V5 (supplementary material Fig. S2).
Leptomycin treatment of GFP-expressing cells did not induce
these markers (Fig. 6C), indicating that accumulation of Ankle1
in the nucleus, but not Leptomycin treatment and/or transfection,
activated the DNA damage signaling pathway. Nuclear
accumulation of a C-terminally truncated Ankle1 protein
missing the GIY-YIG motif (GFP–Ankle1DCT) did not
activate the DNA damage response pathway (Fig. 6D). These
observations indicate that accumulation of Ankle1 in the nucleus
causes DNA cleavage, thereby activating the DNA damage
response pathway.
The LEM domain of Ankle1 is required for DNA cleavage
in vivo
Defined DNA binding and targeting motifs described in homing
endonucleases, such as zinc-finger domains, helix-turn-helix
motifs and DNA minor groove-binding a-helical structures
(Derbyshire et al., 1997; Kowalski et al., 1999; Liu et al.,
2006; Carter et al., 2007), are not known in Ankle1 therefore we
hypothesized that the LEM motif of Ankle1 might be involved in
correct targeting of the protein. In order to test whether the LEM
domain is involved in Ankle1-mediated DNA cleavage, we
measured cH2A.X staining intensity in mixed cultures of
cells expressing either full-length Ankle1 or the LEM-domain-
deficient variant Ankle1b. To correlate the extent of DNA
damage (cH2A.X staining intensity) with Ankle1 expression
levels in individual cells, we also measured the intensity of the
V5 staining. Unlike Ankle1b, full-length Ankle1 was expressed
from a vector also expressing a GFP marker, allowing us to
discriminate between cells expressing full-length Ankle1 or
Ankle1b in the mixed culture (Fig. 7). Immunofluorescence
analyses of mixed cell populations were performed before and
after Leptomycin treatment (Fig. 7). The fluorescence intensity
of the V5-specific signal in the nucleus of Leptomycin-treated
cells was measured in GFP-positive cells (i.e. cells expressing
full-length Ankle1–V5) and GFP-negative cells (expressing
Ankle1b–V5) and plotted over the intensity of cH2A.X-specific
fluorescence (Fig. 7). DNA damage (measured via cH2A.X
intensity) increased with increasing levels of full-length Ankle1,
whereas only low levels of cH2A.X were detectable in Ankle1b-
expressing cells independently of the expression level (Fig. 7).
Fig. 5. Ankle1 cleaves DNA in vitro and in vivo. (A) Purified wild-type and mutated HA-Strep-Ankle1 expressed in HEK cells was incubated with supercoiled
pFastBac1 plasmid and the DNA species separated by agarose gel electrophoresis. Arrows indicate different intermediate steps of plasmid degradation (o.circ,
open circle or nicked; lin, linear; sp.coil, supercoiled; deg, degraded). (B) Representative images of ethidium-bromide-stained nuclei in a Comet assay. Scale bars:
10 mm. Comets were measured using the Comet Assay IV software, quantified and visualized in Graphpad Prism. Median values are indicated as horizontal lines.
***P,0.001 indicates statistically significant differences in median values between populations. Comet formation (i.e. DNA fragmentation) was evaluated
in single cells of three independent cell populations (n.50 each).
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Thus, the presence of a functional LEM motif is required for the
Ankle1-mediated activation of the DNA response pathway,
suggesting that this domain might be involved in targeting
Ankle1 to chromatin in vivo.
Discussion
In this study we performed biochemical and cell biological
analyses of a previously uncharacterized human LEM protein,
annotated as Ankle1 in databases. The LEM domain of Ankle1
interacts with BAF, confirming that Ankle1 is a bona fide
LEM protein. Apart from its interaction with BAF, Ankle1 also
showed four unexpected novel and unique properties among
the characterized LEM protein family members: (1) Ankle1
expression is largely restricted to hematopoietic tissues, whereas
most other LEM proteins in mammals are widely expressed
(Theodor et al., 1997; Ellis et al., 1998; Lin et al., 2000; Brachner
et al., 2005). Only LEMD1 (also known as LEM5) (Lee and
Wilson, 2004) has so far been reported to be expressed in a
tissue-restricted manner (testis) (Yuki et al., 2004). (2) Although
all analyzed LEM proteins contain a LEM motif close to their
nucleoplasmic N-terminus (Wagner and Krohne, 2007), the LEM
domain of Ankle1 is located in the middle of the polypeptide. (3)
Ankle1 lacks transmembrane domains and shuttles in and
out of the nucleus. Non-membrane-bound localization among
characterized LEM proteins has only been reported for two
isoforms of the LAP2-encoding gene, LAP2a (Dechat et al.,
1998; Dechat et al., 2004) and LAP2j (Shaklai et al., 2008). All
other studied LEM proteins contain one or two transmembrane
domains and localize to the inner nuclear membrane. (4) The
most intriguing and exceptional feature of Ankle1, however, is an
enzymatically active GIY-YIG motif that has been previously
described in homing endonucleases and a few other proteins,
Fig. 6. Accumulation of ectopic Ankle1 in the nucleus causes DNA damage. (A–D) HeLa cells were transiently transfected with GFP–Ankle1 (A), GFP (C) or
GFP–Ankle1DCT (D) and treated with Leptomycin as indicated, or incubated with Etoposide (B). All samples were processed in parallel for confocal
immunofluorescence microscopy. Fixed cells were stained for 53BP1, cH2A.X or phosphorylated Chk2 using specific antibodies (all red), DNA was stained with
DAPI (blue), GFP and GFP-fusion proteins are shown in green. Arrows indicate the cells shown in the insets. Representative images out of at least three
independent experiments. Scale bars: 10 mm.
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including the bacterial nucleotide excision repair protein UvrC
and the DNA structure-specific repair enzyme SLX1 in humans
(Perrin et al., 1993; Stoddard, 2005; Truglio et al., 2005; Dunin-
Horkawicz et al., 2006; Edgell, 2009; Fekairi et al., 2009;
Svendsen et al., 2009). The comparison of 3D models generated
from the canonical GIY-YIG homing endonuclease I-TevI and
from human, C. elegans and hydra Ankle1 revealed striking
similarities (supplementary material Fig. S3), indicating a strong
structural conservation between I-TevI and Ankle1 proteins
despite low primary sequence identity. Thus, Ankle1 is an
unusual member of the LEM protein family and is, along with
SLX1, the only active GIY-YIG-type endonuclease so far
described in higher eukaryotes.
Besides the catalytically active GIY-YIG domain, homing
endonucleases also contain DNA-binding motifs such as zinc-
finger, a-helix and helix-turn-helix domains that position the
catalytic core at the DNA. It is tempting to speculate that Ankle1
is targeted to DNA through the interaction between its LEM
domain and BAF. In addition, a DNA-binding a-helix might be
present within the C-terminus of Ankle1 according to in silico
modeling (supplementary material Fig. S3B), but so far we have
no experimental evidence for additional DNA binding motifs in
Ankle1. Our hypothesis that a Ankle1–BAF complex is involved
in DNA cleavage is supported by the observation that the
LEM-deficient splice isoform Ankle1b, did not induce DNA
damage response.
What is the physiological role of Ankle1?
When forced to the nucleus by transient inhibition of nuclear
export, Ankle1 caused DNA cleavage and induced DNA damage
response. In all organisms, endonucleases are instrumental in
diverse DNA repair pathways (Nishino and Morikawa, 2002; Marti
and Fleck, 2004). Endonucleases are also essential for the
processing of double-strand breaks introduced during meiotic
recombination (Borde, 2007; Mimitou and Symington, 2009)
and for somatic genomic rearrangements during lymphocyte
development in higher eukaryotes (Lieber et al., 2004; Rooney
et al., 2004; Rivera-Munoz et al., 2007). Taking into account the
predominant expression of human Ankle1 in hematopoietic tissues
and in lymphoma-derived cell lines, we postulate a role of Ankle1
in genomic rearrangement or associated DNA repair processes
during the development of lymphocytes. In addition, Ankle1 might
have a more general function in DNA repair pathways, which could
explain its conservation in lower metazoan species. Consistent with
this hypothesis, others have demonstrated that loss of function of
the C. elegans ortholog of mammalian Ankle1, lem-3, causes
a radiation hypersensitivity (Rad) phenotype (Christina Dittrich
and Michael Hengartner, University of Zurich; personal
Fig. 7. LEM domain in Ankle1 is required for induction of DNA damage response. HeLa cells were transfected separately with constructs expressing
Ankle1–V5 or the LEM-domain-deficient Ankle1b–V5 and seeded as a mixed culture onto coverslips after 24 hours. The plasmid expressing Ankle1–V5 also
expresses a CMV-driven GFP–Blasticidin marker gene (GFP-Bsd). The plasmid encoding Ankle1b–V5 contains a Blasticidin gene without GFP fusion (Bsd) (see
plasmid maps on the right). After 48 hours, cells were either treated with Leptomycin or ethanol for 3 hours, fixed, stained for V5 (red) and cH2A.X
(yellow) and imaged on a confocal fluorescence microscope. DNA was stained with DAPI (blue). GFP–Blasticidin is shown in green. Cells marked with asterisks
lack GFP signal and are thus expressing Ankle1b; cells expressing Ankle1 (expressing GFP) are marked with arrows. Scale bars: 10 mm. Bottom right: relative
fluorescence intensities of V5 and cH2A.X signals within the nucleus of untransfected, GFP-positive and GFP-negative transfected and Leptomycin-treated cells
(n.30 each) were measured and plotted using Graphpad Prism software. Representative results out of three independent experiments are shown.
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communication). Worms carrying a leucine to phenylalanine point
mutation in LEM-3 at position 659 (supplementary material
Fig. S3C) are hypersensitive to DNA damage caused by
chemicals and irradiation. This leucine residue is invariably
conserved in all identified Ankle1 proteins at the respective
positions. Interestingly, this site resides within a predicted C-
terminal a-helical structure (supplementary material Fig. S3B,C)
and thus could be important for Ankle1-DNA coordination.
Interestingly, human Ankle1 mutated at the respective residue
(L590F) did not trigger the DNA damage response pathway upon
accumulation in the nucleus (supplementary material Fig. S4).
Altogether, the results indicate that Ankle1 is an evolutionary
conserved GIY-YIG-type endonuclease that is predicted to have
functions in DNA damage repair pathways in lower metazoan
organisms (Christina Dittrich and Michael Hengartner, personal
communication), whereas it seems to have acquired more
specialized functions during evolution in mammals, particularly
in human lymphocyte development.
Materials and Methods
Cell culture and reagents
HeLa, HEK, SW-480, T-98-G and U2-OS cells were routinely cultivated in
DMEM; ARH-77, CCRF, DAUDI, K-562, VL-6, RAJI, RAMOS and REH cells
were cultivated in RPMI, both supplemented with 10% fetal calf serum
(Invitrogen, Carlsbad, CA), 100 U/ml penicillin/streptomycin and 2 mM L-
glutamine at 37 C˚ in a humidified atmosphere containing 8.5% CO2 and 5% CO2
respectively. Transient transfections were performed using Nanofectin according
to the manufacturer’s instructions (PAA, Pasching, Austria). Crm-dependent
nuclear export was inhibited with 10 ng/ml Leptomycin B (Enzo Life Sciences,
Lausen, Switzerland) in complete growth medium for 1–3 hours.
PCR analyses
Poly(A+) RNA purified from cell lines using the mRNA isolation kit (Roche,
Mannheim, Germany) or purchased human tissue total RNA samples from Agilent
Technologies (Santa Clara, CA) and Biochain (Hayward, CA) were reverse
transcribed using the First-strand cDNA Synthesis Kit (Roche, Mannheim,
Germany). Aliquots of the resulting products were used as templates for PCR
amplification of Ankle1, actin and GAPDH using the Go-Taq PCR Master Mix
(Promega, Germany) and the following primer pairs: Ankle1 forward(1) 59-
TGCCTGTGGGAGCACCAGACATC-39, Ankle1 forward(2) 59-GCCCTGCG-
GACGGGCTGTATTC-39, Ankle1 reverse 59-GCTCGCCTTCAGCCAGGAA-
GAC-39, actin forward 59-ATCTGGCACCACACCTTCTAC-39, actin reverse
59-CAGCCAGGTCCAGACGCAGG-39, GAPDH forward 59-CATCACCATCT-
TCCAGGAGCGA-39 and GAPDH reverse 59-CCTGCTTCACCACCTTCT-
TGAT-39.
Antibodies
Mouse antibodies against V5 were purchased from Invitrogen, rabbit anti-actin
from Sigma-Aldrich, rabbit anti-53BP1 and mouse anti-BAF both from Novus
Biologicals (Littleton, CO), and rabbit antibody against phosphorylated Chk2
(Thr68) from Cell Signaling Technology (Boston, MA). The MANEM5 anti-
emerin antibody was a kind gift from Glenn Morris, NE Wales Institute, Wrexham,
UK (Manilal et al., 1996). Polyclonal rabbit anti-murine Ankle1 antibodies were
raised against an N-terminal fragment encompassing amino acids 95–260,
following the Austrian and European regulations on animal experimentation.
Antibodies against Ankle1 were affinity purified from serum number 136 using a
purified recombinant human Ankle1 fragment corresponding to mouse Ankle1
amino acids 95–260. His-tagged proteins were detected using the India HisProbe-
HRP (Pierce Biotechnology, Rockford, IL).
Plasmids and cloning strategy
Human Ankle1 and the splice variant Ankle1b were amplified from bone marrow
cDNA using the Platinum Pfx PCR Kit (Invitrogen). Oligonucleotides used were:
Ankle1-CACC forward 59-CACCGCTAGCATGTGCTCGGAGGCCCGCCTGG-
39 and Ankle1-wostop reverse 59-GTATCTAGAGCCCCGGGCCTGGATGTC-39
or Ankle1-stop reverse 59-TCAGCCCCGGGCCTGGATG-39. PCR products
were cloned into pENTR/D-TOPO or pET102-TOPO using topoisomerase-
based cloning (Invitrogen). GFP–Ankle1 fusion constructs were created by
PCR amplification using primers Ankle1-SalI forward 59-AGCGTCGACAT-
GTGCTCGGAGGCCCGCCTGG-39 and Ankle1-stop reverse. The PCR product
was cut with SalI and ligated into SalI and SmaI sites of the peGFP-C1 vector
(Clontech, Palo Alto, CA). The deletion construct human Ankle1DCT (amino
acids 1–420) was constructed by cloning the PCR-generated fragment into
pET102-TOPO and peGFP-C1 using the same cloning strategies as described
above, using the respective forward primers and the primer human Ankle1-1062-
stop reverse 59-CATTCTAGACCGGCTACAAGGGCCGACAG-39. V5-tagged
Ankle1 was generated by shuttling Ankle1 via the LR-recombination reaction
(Invitrogen) from pENTR plasmids into a Gateway-compatible pTRACER
plasmid (pTB) (Brachner et al., 2005) or pDEST-51 (Invitrogen). Quick-change
site directed mutagenesis was performed according to the manufacturer’s protocol
(Stratagene, Santa Clara, CA) by amplification of pEntry-hAnkle1 with primers
containing the desired mutations. Introduced point mutations were verified by
sequencing, and Ankle1 mutants were shuttled into pTB or pDEST-51. The HA-
Strep-Ankle1 plasmid was generated by cloning the PCR-amplified human Ankle1
cDNA into the pENTR11 vector (Invitrogen) followed by Gateway-mediated
shuttling into the pTO_HA_StrepIII_GW_FRT vector (obtained from Matthias
Gstaiger, ETH, Switzerland). PCR-generated human BAF cDNA was cloned via
the topoisomerase reaction into pET102-D-Topo for bacterial expression with a C-
terminal His tag or with a downstream stop codon into pEntry-D-Topo. The
pEntry-hBAF-stop was then used for Gateway cloning into the bacterial expression
vector pDEST42.
Preparation of cell lysates, gel electrophoresis and immunoblotting
Cells were harvested, washed in cold PBS and resuspended in cold high-salt RIPA
buffer [25 mM Tris-HCl pH 7.4, 500 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 0.1% SDS, Complete protease inhibitor mix (Roche, Mannheim,
Germany), 1 mM PMSF and 1 mM DTT]. Following incubation on ice for
10 minutes, cell lysates were sonicated for 5 seconds and the insoluble material
pelleted. Supernatants were mixed with Laemmli sample buffer, boiled for
3 minutes and resolved via polyacrylamide gel electrophoresis. Proteins were
blotted onto nitrocellulose membranes and probed with antibodies. After
incubation with horse-radish-peroxidase-conjugated secondary antibodies, the
Supersignal West Pico chemiluminescent substrate and CL-XPosure films
(ThermoFisher Scientific, Rockford, IL) were used to detect signals.
Pull-down assay
Bacterial expression vectors containing human Ankle1a (pET102-hAnkle1a-stop or
pET102-hAnkle1a-66His-V5), human Ankle1b (pET102-hAnkle1b-66His-V5),
human Ankle1DCT (pET102-hAnkle1DCT-stop), human BAF (pET102-hBAF-
66His or pDEST42-hBAF-stop), human LAP2a (pDEST42-hLAP2a-66His-V5)
or EmerinDTM (pET11c-EmerinDTM, kindly provided by Kathy Wilson, Johns
Hopkins University, Baltimore, MD) were transformed into BL21-star (Invitrogen).
After induction of recombinant protein expression with 1 mM IPTG for 3 hours at
37 C˚, bacteria were lysed in RIPA buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl,
1% NP-40, 1% sodium deoxycholate, 0.1% SDS, Complete protease inhibitor mix,
1 mM PMSF and 1 mM DTT) and sonicated for 1 minute on ice. Insoluble material
was pelleted and 20 ml of soluble fractions containing human Ankle1-stop, human
Ankle1DCT-stop or EmerinDTM were mixed with 10 mg of human BAF-66His
and incubated for 1 hour at 37 C˚ in 100 ml pull-down buffer (20 mM Tris-HCl pH
7.4, 150 mM NaCl, 10 mM imidazole, 0.5% NP-40, 1 mM EDTA and protease
inhibitor mix). BAF complexes were separated with magnetic Ni2+beads (Promega),
washed three times with pull-down buffer, eluted by incubation with HEPES elution
buffer (100 mM HEPES pH 7.4, 500 mM imidazole and 1 mM DTT) for
10 minutes and analyzed by western blotting. Pull down of untagged human
BAF-stop was carried out as follows: 20 ml of lysate containing BAF-stop were
mixed with 20 ml of lysate of BL21 bacteria expressing human Ankle1a-66His-V5,
human Ankle1b-66His-V5 or human LAP2a-66His-V5) in 100 ml of pull-down
buffer and incubated for 1 hour at 37 C˚. Complexes were precipitated with magnetic
Ni particles, washed three times with pull-down buffer and analyzed by western
blotting.
Immunofluorescence
Cells were grown on poly-L-lysine-coated glass coverslips or seeded into Ibidi-treat
microscopy slides for live-cell imaging (see Fig. 4A) (Ibidi, Munich, Germany).
Cells on coverslips were fixed in PBS containing 4% paraformaldehyde for
10 minutes and permeabilized in PBS containing 0.5% Triton X-100 for 5 minutes.
Cells were blocked in PBS containing 0.5% gelatin for 15 minutes, incubated with
primary antibodies for 45 minutes, washed three times with PBS and re-probed with
the appropriate secondary antibodies conjugated to either TexasRed or Cy-5
(Jackson ImmunoResearch) for 45 minutes. After three washes with PBS, DNA was
counterstained with 100 ng/ml DAPI (Sigma, Munich, Germany) for 5 minutes and
samples mounted in Mowiol (Fluka, Buchs, Switzerland). Images were taken using a
confocal laser scanning microscope (LSM-Meta, Zeiss, Jena, Germany) using a
Plan-Apochromat 636 oil immersion objective (NA 1.40). Live-cell imaging was
performed on the same microscope with transfected cells seeded. Digital images
were analyzed, adjusted for brightness and contrast, and mounted using the LSM
Image-Browser (Zeiss, Jena, Germany) and Adobe Illustrator (Adobe Systems, San
Jose, CA).
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Computer-assisted analysis
Sequence alignments and database searches were performed by NCBI-BLAST
(http://www.ncbi.nlm.nih.gov/blast/), GraphAlign (http://darwin.nmsu.edu/cgi-bin/
graph_align.cgi) (Spalding and Lammers, 2004) and ClustalW2 (http://www.ebi.ac.
uk/clustalw2/) (Thompson et al., 1994). Genomic analysis was done using
the ENSEMBL Genome Browser (http://www.ensembl.org/) (Sanger Institute).
Additional human Ankle1 orthologs were predicted using the GENSCAN software
(http://genes.mit.edu/genscan.html) (Burge and Karlin, 1997). Protein motifs and
pattern searches were performed using SMART (http://smart.embl-heidelberg.de/)
(Schultz et al., 1998; Letunic et al., 2004) and PSORT-II (http://psort.nibb.ac.jp/
form2.html). Transmembrane domains were calculated using the TMHMM 2.0
prediction software (http://www.cbs.dtu.dk/services/TMHMM/) (Krogh et al., 2001)
and the DAS-TMfilter algorithm (Cserzo et al., 2004). Phylogenetic tree predictions
were visualized using the Phylodendron and PhyloDraw software (Choi et al., 2000).
3D modeling was performed employing the CPHmodels 3.0 Server (Nielsen
et al., 2002) and visualized using the Discovery Visualizer Studio 2.5 (Accelrys
Software, San Diego, CA).
COMET assay
Alkaline single cell gel electrophoresis (COMET assays) were performed as
described previously (Ehrlich et al., 2008). In brief, GFP-positive HeLa cells were
sorted by fluorescence-activated cell sorting (FACS), pelleted and embedded in a
thin layer of low-melting agarose (Invitrogen) on microscopy slides. In order to
prevent DNA damage caused by UV light, lysis and all subsequent steps were
conducted under red light. After solidification of the agarose, slides were
immersed in lysis buffer (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris-HCl, 1%
Triton X-100, 10% dimethyl sulfoxide, pH 10.0) at 4 C˚ for at least 1 hour. DNA
was unwound by incubation of slides in alkaline electrophoresis buffer (300 mM
NaOH, 1 mM Na2EDTA, pH$12.5) for 20 minutes followed by electrophoresis
for 20 minutes at 25 V and 300 mA. Then, the slides were neutralized by two 10-
minute incubations in neutralization buffer (0.4 M Trizma base, pH 7.5) at 4 C˚.
Slides were air-dried and stained with ethidium bromide. Formation of ‘comets’
was measured in randomly chosen nuclei (n.150) for each condition in three
independent samples using the Comet Assay IV software (Perceptive Instruments,
Haverhill, UK), and quantified and visualized in Graphpad Prism.
Endonuclease assays with HA-Strep Ankle1
HEK293 cells transiently transfected with a vector expressing HA-Strep-Ankle1
were grown on 15-cm dishes to 80% confluency. At 24 hours after transfection, the
cells were pelleted by centrifugation, washed in PBS and snap-frozen. The pellets
were lysed (20 mM HEPES-KOH pH 8.0, 200 mM NaCl, 1% Triton X-100,
1 mM EDTA, 10% glycerol and protease inhibitors) and incubated on ice for
20 minutes. The lysate was centrifuged and incubated with Streptactin beads (IBA
biotechnology, Go¨ttingen, Germany) for 2 hours at 4 C˚ on a rotating wheel
(300 r.p.m.). Subsequently, the beads were washed three times with 1 ml lysis
buffer and twice with 1 ml wash buffer (20 mM HEPES-KOH pH 7.5, 2 mM
MnCl2, 0.05 mg/ml BSA and 50 mM KCl); each wash was for 5 minutes at 4 C˚.
HA-Strep Ankle1 was finally eluted in 100 ml of PBS containing 2.5 mM
desthiobiotin (IBA Biotechnology) for 30 minutes at 4 C˚ on a shaker (600 r.p.m.).
Aliquots were immediately snap-frozen.
For the nonspecific endonuclease assays, 80 ng of supercoiled pFastBac1
plasmid was incubated with wild-type Ankle1 or its variants in endonuclease
buffer (20 mM HEPES-KOH pH 7.4, 2 mM MnCl2, 45 mM KCl, 50 mg/ml BSA).
After incubation at 37 C˚ for 1 hour, the reaction was terminated by the addition of
0.1% SDS, 14 mM EDTA and 0.1 mg/ml proteinase K and incubation at 55 C˚ for
15 minutes. Then, 10% glycerol was added and the samples separated on a 0.8%
ethidium bromide agarose gel for 45 minutes at 80 V.
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